XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.25.3

REVENUE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Revenue from Contract with Customer [Abstract] |
Schedule of Total Revenue by Type and by U.S versus Rest of World | The following table presents details regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):
| Three Months Ended September 30,
| 2025 |  |  | 2024
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Hereditary Cancer | $ | 81.8 |  |  | $ | 11.2 |  |  | $ | 93.0 |  |  |  | $ | 78.4 |  |  | $ | 12.1 |  |  | $ | 90.5 |
Tumor Profiling | 26.7 |  |  | 2.8 |  |  | 29.5 |  |  |  | 26.5 |  |  | 5.1 |  |  | 31.6 |
Prenatal | 44.5 |  |  | — |  |  | 44.5 |  |  |  | 43.4 |  |  | 0.1 |  |  | 43.5 |
Pharmacogenomics | 38.7 |  |  | — |  |  | 38.7 |  |  |  | 47.7 |  |  | — |  |  | 47.7 |
Total revenue | $ | 191.7 |  |  | $ | 14.0 |  |  | $ | 205.7 |  |  |  | $ | 196.0 |  |  | $ | 17.3 |  |  | $ | 213.3 |
| Nine months ended September 30,
| 2025 |  |  | 2024
(in millions) | U.S. |  | RoW |  | Total |  |  | U.S. |  | RoW |  | Total
Hereditary Cancer | $ | 241.8 |  |  | $ | 33.8 |  |  | $ | 275.6 |  |  |  | $ | 235.6 |  |  | $ | 34.5 |  |  | $ | 270.1 |
Tumor Profiling | 81.0 |  |  | 9.2 |  |  | 90.2 |  |  |  | 77.1 |  |  | 18.0 |  |  | 95.1 |
Prenatal | 141.2 |  |  | 0.2 |  |  | 141.4 |  |  |  | 131.7 |  |  | 0.5 |  |  | 132.2 |
Pharmacogenomics | 107.5 |  |  | — |  |  | 107.5 |  |  |  | 129.6 |  |  | — |  |  | 129.6 |
Total revenue | $ | 571.5 |  |  | $ | 43.2 |  |  | $ | 614.7 |  |  |  | $ | 574.0 |  |  | $ | 53.0 |  |  | $ | 627.0 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration